Contract HHSO100201600009C

Cerus Corporation · Department Of Health And Human Services · September 27, 2022

Cost No FeeFull & Open CompetitionNAICS 541711

Cerus Corporation was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 27, 2022 for $197.76 million (current value) of work in research and development in biotechnology. Performance is in Concord, CA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost no fee contract pricing. The most recent modification was on February 20, 2026. If all options are exercised, the contract could reach $282.45 million.

Current value
$197.76M
Potential value
$282.45M
if all options exercised
Modifications
2
Latest February 20, 2026

Contract details

PIID
HHSO100201600009C
Award type
Definitive Contract
Pricing
Cost No Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541711 · Research And Development In Biotechnology
Product / service
Health R&D Services; Health Care Services; Experimental Development
Place of performance
Concord, CA
First action
September 27, 2022
Latest action
February 20, 2026

Description

THE PURPOSE OF THIS NO COST MODIFICATION IS TO ADMINISTRATIVELY CORRECT THE CONTRACT CLINS PERIOD OF PERFORMANCE IN THE PRISM CONTRACT WRITING SYSTEM IN ORDER TO ALIGN IT FOR INVOICING.

Modification timeline

  • February 20, 2026
    Mod P00030 · Other Administrative Action
    $185.47M
  • September 21, 2025
    Mod P00029 · Other Administrative Action
    THE PURPOSE OF THIS MODIFICATION: 1. NO COST EXTENSION FOR OPTION 01 (CLIN 0002), 2. REVISE KEY PERSONNEL, AND 3. REVISE THE STATEMENT OF WORK.
    $185.47M
  • September 27, 2022
    Mod P00021 · Funding Only Action
    CERUS - DE-OBLIGATION OF EXPIRING FUNDS.
    $185.47M

Similar contracts

RecipientAgencyDateObligated
University Of IllinoisDepartment Of Health And Human ServicesMarch 26, 2026$2.27M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 25, 2026$9.65M
University Of Texas Medical Branch At GalvestonDepartment Of Health And Human ServicesMarch 23, 2026$1.61M
Regeneron Pharmaceuticals IncDepartment Of Health And Human ServicesMarch 19, 2026$8.60M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.23M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.22M

Top contractors in NAICS 541711

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Alliance For Energy Innovation, Llc1$338.10M
2Battelle National Biodefense Institute, Llc2$24.13M
3Battelle Memorial Institute7$2.21M
4Bradshaw Engineering And Technical Services Llc1$0
5Uk Health Security Agency1$0
6Medicines Company, The1$0
7University Of North Carolina At Chapel Hill1$0
8Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center1$0
9Dnae Group Holdings Limited1$0
10University Of Texas Medical Branch At Galveston2$0

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSO100201600009C?

Contract HHSO100201600009C is a federal contract awarded to Cerus Corporation by Department Of Health And Human Services on September 27, 2022 for $197.76 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 2 times since the base award.

Who won contract HHSO100201600009C?

Cerus Corporation won contract HHSO100201600009C from Department Of Health And Human Services.

How much is contract HHSO100201600009C worth?

Contract HHSO100201600009C has obligated $0 to date but carries a potential ceiling of $282.45 million if fully funded and all options are exercised.